![Jaap Koopman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Jaap Koopman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | - |
Oprichter | 01-01-2004 | - | |
Fibriant BV
![]() Fibriant BV Pharmaceuticals: OtherHealth Technology Fibriant BV is a Dutch biotechnology company that specializes in the recombinant manufacturing and characterization of specific variants of human Fibrinogen and active human Thrombin. The company is based in Leiden, the Netherlands. The company's science and technology are centered around Fibrinogen, a soluble blood protein that can be converted into an insoluble three-dimensional Fibrin network. Fibriant captures the unique features and functions of specific recombinant variants of Fibrinogen in new innovative products and in improvements of existing products based on plasma Fibrinogen. The company was founded in 2015 by Jaap Koopman, Jos Grimbergen, Miranda Weggeman, and Jaap Koopman has been the CEO since then. | Algemeen Directeur | 01-01-2015 | - |
Oprichter | 01-01-2015 | - |
Loopbaan van Jaap Koopman
Eerdere bekende functies van Jaap Koopman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PHARMING GROUP N.V. | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 | 01-01-2003 |
Opleiding van Jaap Koopman
University of Leiden | Doctorate Degree |
Statistieken
Internationaal
Nederland | 5 |
Operationeel
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PHARMING GROUP N.V. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Health Technology |
Fibriant BV
![]() Fibriant BV Pharmaceuticals: OtherHealth Technology Fibriant BV is a Dutch biotechnology company that specializes in the recombinant manufacturing and characterization of specific variants of human Fibrinogen and active human Thrombin. The company is based in Leiden, the Netherlands. The company's science and technology are centered around Fibrinogen, a soluble blood protein that can be converted into an insoluble three-dimensional Fibrin network. Fibriant captures the unique features and functions of specific recombinant variants of Fibrinogen in new innovative products and in improvements of existing products based on plasma Fibrinogen. The company was founded in 2015 by Jaap Koopman, Jos Grimbergen, Miranda Weggeman, and Jaap Koopman has been the CEO since then. | Health Technology |
- Beurs
- Insiders
- Jaap Koopman
- Ervaring